Definition and Overview
Transcutaneous vagus nerve stimulation (tVNS) is a non-invasive neuromodulation therapy that stimulates the vagus nerve (cranial nerve X) by attaching skin electrodes to the auricle or cervical region without surgery.
The vagus nerve originates from the brainstem and is widely distributed throughout the cervical, thoracic, and abdominal regions, playing a key role in autonomic regulation of the cardiovascular, respiratory, and digestive systems, as well as immune and inflammatory response modulation. tVNS has gained attention as an alternative to implantable vagus nerve stimulation (VNS) because it can activate this nerve without invasive procedures.
There are two main stimulation approaches. Auricular tVNS (atVNS) stimulates the auricular branch of the vagus nerve (Arnold's nerve), which innervates the external ear canal or tragus. Cervical tVNS (ctVNS) stimulates the vagus nerve trunk through the anterior cervical skin.
Mechanism of Action
The primary mechanisms of action of tVNS are as follows.
Afferent fibers of the vagus nerve reach the nucleus tractus solitarius (NTS) in the brainstem, transmitting signals throughout the central nervous system. Projections from the NTS extend to the locus coeruleus, hypothalamus, limbic system, and other regions, inducing a range of physiological effects.
The cholinergic anti-inflammatory pathway is one of the important mechanisms of tVNS. Vagus nerve activation induces acetylcholine release through splenic T cells, inhibiting the production of pro-inflammatory cytokines such as TNF-alpha by macrophages.
Blood pressure and heart rate stabilization through baroreflex modulation, increased parasympathetic tone, and synaptic plasticity changes are also being investigated as key effects of tVNS.
Indications
The major clinical applications of tVNS are as follows.
For migraine prevention, studies in patients with episodic migraine have reported significant reductions in monthly headache days [1].
For cluster headache, a cervical device (gammaCore, electroCore) received U.S. FDA approval in 2019 for both prevention and acute treatment of cluster headache.
For depression and anxiety disorders, some studies have shown that auricular tVNS produces significant mood improvement compared to sham stimulation [3], although large-scale RCT results are still insufficient.
Applications for epilepsy and autonomic dysfunction are also in the investigational stage.
Procedure
Auricular tVNS involves placing a small electrode clip or adhesive electrode on the tragus or around the external ear canal and periodically delivering low-current (approximately 1-2 mA) electrical stimulation. Session duration is typically 20-30 minutes, applied 1-2 times daily, and some devices allow self-administration.
Cervical tVNS delivers stimulation by pressing a gel-coated electrode handpiece against the cervical skin. Devices suitable for use in both clinical settings and at home have been developed.
Stimulation intensity, frequency, and waveform vary by device, and protocols differ according to clinical indications.
Efficacy and Evidence
For migraine prevention, the study by Silberstein et al. (2016) reported that cervical tVNS significantly reduced monthly headache days [1]. Barbanti et al. (2015) also confirmed significant efficacy in patients with high-frequency migraine [2].
Regarding effects on autonomic function, studies have reported that auricular tVNS tends to increase heart rate variability (HRV) and decrease resting heart rate [4].
With respect to central nervous system effects, Frangos et al. (2015) confirmed via fMRI that auricular tVNS alters activity in the brainstem NTS and related structures [4].
Basic and clinical research on anti-inflammatory effects is also accumulating; however, optimal protocols and long-term effects for each indication are still being established.
Precautions and Contraindications
Caution is required or tVNS is contraindicated in the following cases.
Patients with pacemakers, implantable cardioverter-defibrillators (ICDs), or other active implantable medical devices are restricted from use due to electromagnetic interference concerns. Patients with carotid artery stenosis, history of cervical surgery, or skin infections or wounds at the electrode attachment site also require specialist evaluation prior to the procedure.
Sufficient safety data regarding tVNS use during pregnancy are not yet available, and specialist consultation is recommended before use.
Common side effects include skin redness, itching, and mild discomfort at the electrode site. For cervical devices, voice changes, cough, and nausea are rarely reported.
---
This information is provided for medical educational purposes and does not replace individual medical consultation or treatment. If you have symptoms, please consult a specialist. Contact: OSANG Neurosurgery 1599-5453 | osns.co.kr